http://www.mayomedicallaboratories.com/articles/hottopics/2012/06-pharm/index.html In recent years, the Food and Drug Administration has introduced pharmacogenetic-related drug label warnings and precautions, including black box warnings, on some widely prescribed drugs in an effort to reduce adverse effects. Advances in the study of pharmacogenomics have resulted in development of tests to identify patients who would benefit from different treatment levelsContinue reading “The Use of Genetics in Guiding Therapy from Mayo Clinic”